Skip to main content
Galvanta Pharma
  • Company
  • Services
  • Manufacturing
  • Quality
  • Portfolio
  • Business
  • Regulatory
  • Safety
  • Contact
Khmer
MenuClose menu
  • Company
  • Services
  • Manufacturing
  • Quality
  • Portfolio
  • Business
  • Regulatory
  • Safety
  • Contact

Rules for website access

This policy applies to access to galvanta.com and information submitted to GALVANTA COMPANY LIMITED through its website.

Effective: 23 September 2026. Last reviewed: 23 September 2026.
On this pageLawful useProhibited conductAutomated accessSubmissionsProtective measuresReporting and changes

Lawful use

Visitors may read, link to and use website information for lawful personal, professional, academic or institutional purposes, subject to applicable rights and the Terms of use.

Access does not confer permission to use the company’s identity, represent it, or obtain access to non-public records.

Prohibited conduct

Do not:

  • impersonate the company, a regulator, healthcare professional or another person;
  • submit fraudulent, malicious or unlawfully disclosed material;
  • introduce malware or interfere with availability or integrity;
  • attempt unauthorised access or evade technical restrictions;
  • use website content to misrepresent an approval, product, business relationship or authority;
  • facilitate unlawful promotion, diversion, importation or supply of medicines;
  • collect information through abusive automated activity.

Good-faith complaints, lawful criticism and reporting to public authorities are not prohibited by this policy.

Automated access

Ordinary search-engine indexing and non-disruptive reference use are permitted subject to applicable law, published technical controls and intellectual-property rights.

Permission to read public pages is not permission to enumerate protected resources, exploit vulnerabilities or conduct intrusive testing. Obtain express authorisation before security testing that goes beyond ordinary use.

Submissions

Provide only information necessary for the enquiry or report. Do not send passwords, payment details or information belonging to another person without a lawful basis.

A suspected problem may be reported without certainty about its cause. Distinguish observations from assumptions and avoid unnecessary personal accusations or disclosures.

Protective measures

Access may be restricted or rate-limited to protect the service. Relevant records may be preserved where permitted or required by law. These measures do not remove applicable privacy duties or lawful reporting rights.

Reporting and changes

Send misuse concerns to [email protected]. For a vulnerability, follow Website security and disclosure.

This policy may be revised from the stated effective date. It does not create authority to test third-party systems or waive mandatory rights.

Galvanta Pharma

GALVANTA COMPANY LIMITED

A Cambodian company in the pharmaceutical sector, established in Cambodia.

Company registration number 1000634930.

The company holds no pharmaceutical manufacturing licence, GMP certificate, product registration or marketing authorisation.

Official Facebook page

Company information

  • Company
  • Manufacturing
  • Quality
  • Regulatory information
  • Services
  • Product records
  • Business enquiries
  • Contact

Reporting

  • Adverse events
  • Product-quality concerns and recalls
  • Suspected falsification
  • Business conduct
  • Website security

Contact

[email protected]

Registered office

Shop No. 2F-60, Sihanoukville Special Economic Zone
Preah Sihanouk Province, Cambodia

Website policies

  • Legal notice and policies

© 2026 GALVANTA COMPANY LIMITED. Rights reserved to the extent provided by law.

LegalTermsPrivacyCookiesSitemap
English|Khmer